Loading…
Optimi Health Corp. is projected to decline to $4.27 by 2027, a -8% move from its current price of $4.65. Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/11/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $4.38 | $4.65 | $4.93 | -0.03% |
| Jul 14 | $4.28 | $4.65 | $5.05 | -0.06% |
| Jul 15 | $4.20 | $4.65 | $5.14 | -0.09% |
| Jul 16 | $4.13 | $4.64 | $5.22 | -0.12% |
| Jul 17 | $4.07 | $4.64 | $5.29 | -0.15% |
| Jul 18 | $4.02 | $4.64 | $5.36 | -0.19% |
| Jul 19 | $3.97 | $4.64 | $5.42 | -0.22% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $3.97 | $4.64 | $5.42 | -0.22% |
| Week 2 | $3.71 | $4.63 | $5.77 | -0.43% |
| Week 3 | $3.53 | $4.62 | $6.05 | -0.65% |
| Week 4 | $3.38 | $4.61 | $6.29 | -0.86% |
| Week 5 | $3.25 | $4.60 | $6.51 | -1.08% |
| Week 6 | $3.13 | $4.59 | $6.72 | -1.29% |
| Week 7 | $3.03 | $4.58 | $6.91 | -1.50% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Optimi Health Corp. operates as a pharmaceutical and nutraceutical drug manufacturing company in Canada. The company manufactures controlled substances including finished MDMA and psilocybin drug products, supplying them directly to authorized clinics, pharmacies, clinical trials, and partners.
The company produces and supplies MDMA, natural psilocybin, psilocin, other psychedelic substances, and functional mushrooms derived from botanical sources for health and wellness markets. It also engages in farming, processing, and distribution of raw mushroom biomass, mushroom extracts, manufacturing of drug products, and mushroom supplements. It sells its products through Amazon marketplace and distributors/brokers, as well as online.
Optimi Health Corp. was incorporated in 2020 and is based in Princeton, Canada.
Optimi Health Corp. trades under the symbol OPTH in the Healthcare sector. The current price is $4.64 and the market cap is $26.1M, with a rank of 4821.
The price outlook shows a near-term base around the current level, with a 2026 avg of $4.64 and a 2026 max of $6.88. The forecast for 2030 envisions an avg price of $6.33 with a max of $12.81 and a min of $3.11, accompanied by a bullish stance and a 36.4 ROI.
Longer dated forecasts indicate continued upside through 2031 at an avg of $6.32 and 36.2 ROI, then adjustments through 2032-2034 with moderate gains, and a bullish path to 2040 (avg $6.03, ROI 29.9) and 2050 (avg $16.67, max $38.35, ROI 259.3).
A major floor 37.7% below — a decisive break under it would weaken the trend.
The nearest floor, 13.8% below — buyers have tended to step in here.
The nearest ceiling, 28.4% above — a clean break opens room to run.
A major ceiling 46.6% above — clearing it would confirm fresh momentum.
Key OPTH support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of OPTH market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $4.64 | Buy | $4.62 | Buy |
| MA 10 | $4.67 | Sell | $4.63 | Buy |
| MA 20 | $4.51 | Buy | $4.70 | Sell |
| MA 50 | — | Neutral | — | Neutral |
| MA 100 | — | Neutral | — | Neutral |
| MA 200 | — | Neutral | — | Neutral |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 45.15 | Neutral |
| Stoch RSI (14) | 58.32 | Neutral |
| CCI (20) | 18.02 | Neutral |
| Williams %R (14) | -46.30 | Info |
| MACD (12,26,9) | 0.07 | Buy |
| ROC (12) | 10.07 | Buy |
| Bollinger %B (20,2) | 0.56 | Neutral |
| Stochastic %K (14) | 53.70 | Neutral |
| TRIX (15) | — | Neutral |
| Awesome (5,34) | -0.26 | Sell |
| Ultimate (7,14,28) | 22.67 | Buy |
| Momentum (10) | 0.53 | Buy |
| Aroon Osc (25) | -56.00 | Sell |
| Hull MA (9) | 4.51 | Buy |
| ADX (14) | 16.91 | Neutral |
| ATR (14) | 0.23 | Info |
The 30-day technical picture is Neutral. RSI(14) is 50. The near-term range spans from $3.04 to $7.09. There is support at $4.01 and resistance at $5.97, framing a cautious short-term view with upside potential if price tests the upper resistance.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $4.01 | $4.65 | $6.83 | 0% | Neutral | |
| $2.79 | $4.27 | $7.07 | -8% | Neutral | |
| $2.42 | $4.10 | $7.39 | -12% | Neutral | |
| $2.59 | $4.82 | $9.27 | +4% | Neutral | |
| $3.13 | $6.37 | $12.89 | +37% | Bullish | |
| $2.86 | $6.33 | $13.39 | +36% | Bullish | |
| $2.49 | $5.54 | $12.18 | +19% | Neutral | |
| $2.47 | $5.49 | $12.50 | +18% | Neutral | |
| $2.18 | $4.85 | $11.15 | +4% | Neutral | |
| $2.58 | $5.72 | $13.17 | +23% | Bullish | |
| $2.72 | $6.04 | $13.90 | +30% | Bullish | |
| $7.47 | $16.60 | $38.17 | +257% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $4.01 | $4.65 | $5.47 | +0.00% |
| August 2026 | $3.49 | $4.35 | $5.71 | -6.52% |
| September 2026 | $3.55 | $4.52 | $6.12 | +4.00% |
| October 2026 | $3.35 | $4.35 | $6.03 | -3.79% |
| November 2026 | $3.27 | $4.31 | $6.11 | -0.78% |
| December 2026 | $3.54 | $4.74 | $6.83 | +9.77% |
Click any year to see its month-by-month OPTH forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, OPTH could reach as high as $6.83, with a base case around $4.65 and support toward $4.01 — roughly 0% from $4.65. Price action looks broadly range-bound.
Expect OPTH to range from $2.79 to $7.07 through 2027. The $4.27 average target implies a -8% move from current prices. That is -8% versus the projected 2026 average. A consolidation phase looks the most probable path here.
The OPTH price prediction for 2028 points to an average of $4.10 (low $2.42, high $7.39) — a potential decline of -12% on today's $4.65. Price action looks broadly range-bound.
In 2029, OPTH is projected to trade between $2.59 and $9.27, averaging $4.82 — a potential gain of +4% from today's $4.65. That is up +18% on the projected 2028 average. A consolidation phase looks the most probable path here.
Optimi Health Corp.'s 2030 outlook centres on $6.37, within a $3.13 to $12.89 range. That is up +32% on the projected 2029 average. That marks a +37% change versus current levels. Momentum favours further upside here.
By 2031, OPTH could reach as high as $13.39, with a base case around $6.33 and support toward $2.86 — roughly +36% from $4.65. Buyers look set to stay in control over this stretch.
Expect OPTH to range from $2.49 to $12.18 through 2032. The $5.54 average target implies a +19% move from current prices. That is -12% versus the projected 2031 average. Price action looks broadly range-bound.
The OPTH price prediction for 2033 points to an average of $5.49 (low $2.47, high $12.50) — a potential gain of +18% on today's $4.65. A consolidation phase looks the most probable path here.
In 2034, OPTH is projected to trade between $2.18 and $11.15, averaging $4.85 — a potential gain of +4% from today's $4.65. That is -12% versus the projected 2033 average. Price action looks broadly range-bound.
Optimi Health Corp.'s 2035 outlook centres on $5.72, within a $2.58 to $13.17 range. That is up +18% on the projected 2034 average. That marks a +23% change versus current levels. Buyers look set to stay in control over this stretch.
By 2040, OPTH could reach as high as $13.90, with a base case around $6.04 and support toward $2.72 — roughly +30% from $4.65. Momentum favours further upside here.
Expect OPTH to range from $7.47 to $38.17 through 2050. The $16.60 average target implies a +257% move from current prices. That is up +175% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in OPTH today (≈ 215.07689 OPTH) could be worth
$3,569.74
+$2,569.74 (+257%) by 2050 · US Dollar
Based on the average projected OPTH price of $16.6 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in OPTHwould be worth at today's price.
$1,000 invested in OPTH on May 20, 2026 (≈ 164.473686 OPTH) would be worth
$764.72
-$235.28 (-23.5%) today · 0.76× · US Dollar
Based on a OPTH entry price of $6.08 vs. today's $4.65.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $4.88 | $952.77 | -4.7% |
| 1 month ago | $4.67 | $995.61 | -0.4% |
| All time ago | $6.08 | $764.72 | -23.5% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our OPTH forecast.
Our base-case forecast reaches $9.30 around 2050.
Implied market cap at $9.30: $52.32M
The multi-year forecast shows a bullish tilt beginning in 2030, with an average price of $6.33 and an ROI of 36.4, alongside a max of $12.81. The 2031 outlook remains bullish with an average of $6.32 and ROI 36.2, and a max of $13.37. The path includes years with smaller gains (2032 avg $5.54, ROI 19.4; 2033 avg $5.44, ROI 17.2; 2034 avg $4.87, ROI 4.9).
By 2035 the average is $5.74 with ROI 23.7 and a bullish sentiment, and the bullish momentum extends to 2040 (avg $6.03, ROI 29.9). By 2050 the forecast envisions a strong rise to an average of $16.67 with a max of $38.35 and ROI 259.3, indicating substantial long-term upside if the trajectory holds. Note there are years with negative ROI in the interim (e.g., 2027 ROI -9.2 and 2028 ROI -11.8).
Tap a question to reveal the answer.
In 2030 the forecast shows an avg price of $6.33, a min of $3.11, a max of $12.81, and an ROI of 36.4; sentiment is BULLISH.
The forecast starts neutral in 2026 with an avg of $4.64 and ROI of 0, then shows negative ROI in 2027 (-9.2) and 2028 (-11.8) before turning bullish in later years, with a strong upside by 2050 (avg $16.67, ROI 259.3). These are estimates, not guarantees.
Yes. The max prices reach above $10 in several years: $12.81 (2030), $13.37 (2031), $12.18 (2032), $12.38 (2033), $11.20 (2034), $13.20 (2035), $13.86 (2040), and $38.35 (2050).
The 30-day picture shows a Neutral sentiment with RSI(14) of 50. The 30-day range is from $3.04 to $7.09, with support at $4.01 and resistance at $5.97.
The current price is $4.64. The market cap is $26.1M, and the rank is 4821.
Optimi Health Corp. Community Discussion
0Share your Optimi Health Corp. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.